Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Möller, Winfried ^a   Heimbeck, Irene ^b   Hofer, Thomas P J ^a   Khadem Saba, Gülnaz ^a   Neiswirth, Margot ^b   Frankenberger, Marion ^a   Ziegler Heitbrock, Löms ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROGEN PEROXIDE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AEROSOL; ARTICLE; BODY TEMPERATURE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ALVEOLUS; MALE; NEUTROPHIL; PH; PROTEIN BLOOD LEVEL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; VOLUNTEER; BRONCHUS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PNEUMONIA; RESPIRATORY SYSTEM;

ADMINISTRATION, INHALATION; BRONCHI; BRONCHIAL HYPERREACTIVITY; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; PNEUMONIA; PULMONARY ALVEOLI; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM;

EID: 84859358233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033505     Document Type: Article

References (59)

1. Alexander C, Rietschel ET, (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7: 167-202.
2. Zhang P, Summer WR, Bagby GJ, Nelson S, (2000) Innate immunity and pulmonary host defense. Immunol Rev 173: 39-51.
3. Maris NA, Dessing MC, de Vos AF, Bresser P, van der Zee JS, et al. (2006) Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J 28: 622-626.
4. Rietschel ET, Zahringer U, Seydel U, Ulmer AJ, (1999) Bacterial endotoxins: Bioactive conformation and specific host-recognition. Shock 12: 21-21.
5. Mueller-Anneling L, Avol E, Peters JM, Thorne PS, (2004) Ambient Endotoxin Concentrations in PM10 from Southern California. Environ Health Perspect 112: 583-588.
6. Rylander R, (2002) Endotoxin in the environment-exposure and effects. J Endotoxin Res 8: 241-252.
7. Liebers V, Raulf-Heimsoth M, Brüning T, (2008) Health effects due to endotoxin inhalation. Arch Toxicol 82: 203-210.
8. Bolte G, Bischof W, Borte M, Lehmann I, Wichmann HE, et al. (2003) Early endotoxin exposure and atopy development in infants: results of a birth cohort study. Clin Exp Allergy 33: 770-776.
9. Gehring U, Cyrys J, Sedlmeir G, Brunekreef B, Bellander T, et al. (2002) Traffic-related air pollution and respiratory health during the first 2 yrs of life. Eur Respir J 19: 690-698.
10. Shi J, Mehta AJ, Hang J-q, Zhang H, Dai H, et al. (2010) Chronic Lung Function Decline in Cotton Textile Workers: Roles of Historical and Recent Exposures to Endotoxin. Environ Health Perspect 118: 1620-1624.
11. Wedzicha JA, Donaldson GC, (2003) Exacerbations of chronic obstructive pulmonary disease. Respir Care 48: 1204-1213; discussion 1213.
12. Kharitonov SA, Sjöbring U, (2007) Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol 14: 83-100.
13. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
14. Thorn J, (2001) The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm Res 50: 254-261.
15. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, et al. (2005) Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113: 1555-1560.
16. van As A, Webster I, (1972) The organization of ciliary activity and mucus transport in pulmonary airways. S Afr Med J 46: 347-350.
17. Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, et al. (2008) Deposition, retention and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 177: 426-432.
18. Thorley AJ, Grandolfo D, Lim E, Goldstraw P, Young A, et al. (2011) Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung - Role of Alveolar Epithelial TLR Expression and Signalling. PLoS ONE 6: e21827.
19. Ferris BG, (1978) Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 118: 1-120.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16: 5-40.
21. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, et al. (1993) Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 6: 53-83.
22. Brand P, Friemel I, Meyer T, Schulz H, Heyder J, et al. (2000) Total deposition of therapeutic particles during spontaneous and controlled inhalations. J Pharm Sci 89: 724-731.
23. ICRP Publication 66 (1994) Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 24: 1-482.
24. Möller W, Heimbeck I, Weber N, Khadem Saba G, Körner B, et al. (2010) Fractionated Exhaled Breath Condensate Collection Shows High Hydrogen Peroxide Release in the Airways. J Aerosol Med Pulm Drug Deliv 23: 129-135.
25. Gerritsen WB, Zanen P, Bauwens AA, van den Bosch JM, Haas FJ, (2005) Validation of a new method to measure hydrogen peroxide in exhaled breath condensate. Respir Med 99: 1132-1137.
26. Horvath I, Hunt J, Barnes PJ, ATS ERS Task Force Exhaled Breath (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26: 523-548.
27. Hohlfeld JM, Schoenfeld K, Lavae-Mokhtari M, Schaumann F, Mueller M, et al. (2008) Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: A randomized placebo-controlled trial. Pulm Pharmacol Ther 21: 616-623.
28. Scheuch G, Brand P, Meyer T, Müllinger B, Sommerer K, (2002) Regional drug targeting within the lungs by controlled inhalation with the AKITA inhalation system. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory Drug Delivery VIII Richmond, VA, USA Virginia Commonwealth University pp. 165-168.
29. Michel O, Nagy AM, Schroeven M, Duchateau J, Neve J, et al. (1997) Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med 156: 1157-1164.
30. Nightingale JA, Rogers DF, Hart LA, Kharitonov SA, Chung KF, et al. (1998) Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax 53: 563-571.
31. Michel O, Dentener M, Corazza F, Buurman W, Rylander R, (2001) Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol 107: 797-804.
32. Kitz R, Rose MA, Borgmann A, Schubert R, Zielen S, (2006) Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects. J Endotoxin Res 12: 367-374.
33. Peters M, Kauth M, Schwarze J, Körner-Rettberg C, Riedler J, et al. (2006) Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness. Thorax 61: 134-139.
34. Beeson PB, (1947) Tolerance to Bacterial Pyrogens: I. Factors Influencing Its Development. J Exp Med 86: 29-38.
35. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strbel M, Wendelgass P, et al. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269: 17001-17004.
36. Dinarello CA, (2004) Review: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10: 201-222.
37. Beutler B, Rietschel ET, (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176.
38. Tamagawa E, Suda K, Yuan W, Li X, Mui T, et al. (2009) Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immunity 15: 251-258.
39. Christopher MJ, Link DC, (2007) Regulation of neutrophil homeostasis. Curr Opin Hematol 14: 3-8.
40. Levine SJ, Larivée P, Logun C, Angus CW, Shelhamer JH, (1993) Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physiol 265: L360-368.
41. Asano S, (1991) Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Pediatr Hematol Oncol 13: 400-413.
42. Holst H, Edqvist LE, Kindahl H, Rylander R, (1994) Hematological, Blood Biochemical, and Cytological Bronchoalveolar Lavage Studies in Prepubertal Gilts after Endotoxin Inhalation and Ingestion. Journal of Veterinary Medicine Series A 41: 159-166.
43. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I, (1991) Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146: 3032-3037.
44. Mortensen RF, (2001) C-reactive protein, inflammation, and innate immunity. Immunol Res 24: 163-176.
45. Amrani Y, Panettieri RA, (2003) Airway smooth muscle: contraction and beyond. Int J Biochem Cell Biol 35: 272-276.
46. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, et al. (1996) Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 110: 263-270.
47. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
48. Nauseef WM, (2004) Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122: 277-291.
49. Rochelle LG, Fischer BM, Adler KB, (1998) Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 24: 863-868.
50. Lavigne MC, Eppihimer MJ, (2005) Cigarette smoke condensate induces MMP-12 gene expression in airway- like epithelia. Biochem Biophys Res Commun 330: 194-203.
51. Rahman Q, Abidi P, Afaq F, Schiffmann D, Mossman BT, et al. (1999) Glutathione Redox System in Oxidative Lung Injury. Crit Rev Toxicol 29: 543-568.
52. Prince HE, Lapé-Nixon M, (1995) Influence of specimen age and anticoagulant on flow cytometric evaluation of granulocyte oxidative burst generation. J Immunol Methods 188: 129-138.
53. Battin E, Brumaghim J, (2009) Antioxidant Activity of Sulfur and Selenium: A Review of Reactive Oxygen Species Scavenging, Glutathione Peroxidase, and Metal-Binding Antioxidant Mechanisms. Cell Biochem Biophys 55: 1-23.
54. Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA, (1993) Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 150: 2885-2891.
55. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJD, et al. (2000) Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proceedings of the National Academy of Sciences 97: 1778-1783.
56. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, et al. (2003) Loss of integrin [alpha]v[beta]6-mediated TGF-[beta] activation causes Mmp12-dependent emphysema. Nature 422: 169-173.
57. Doyen V, Kassengera Z, Dinh D, Michel O, (2011) Time Course of Endotoxin-Induced Airways' Inflammation in Healthy Subjects. Inflammation pp. 1-6-6 in press.
58. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, et al. (2005) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 172: 878-884.
59. O'Byrne PM, (2007) Exacerbations of asthma and COPD: definitions, clinical manifestations and epidemiology. Contrib Microbiol 14: 1-11.